Search Results | Showing 111 - 120 of 240 results for "Pharmaceutical" |
| | | Australian shares are flat as investors stand by for unemployment data for August. The local market closed at the highest point since June 2008 on Wednesday, after posting several days of gains following a coalition election victory. But CommSec market ... |
| | | | The Australian market looks set to open higher after gains on most international markets overnight with traders cautious despite a possible deal aimed at preventing a US-led military attack on Syria. At 0755 AEST on Thursday, the September share price ... |
| | | | ... stocks, he said the portfolio was comprised of around 75 companies in sectors including software manufacturers, pharmaceutical companies and insurers. While he acknowledged that the strategy is likely to underperform during strongly rising markets, Marx ... |
| | | | The Australian market looks set to open higher after Wall Street gained on positive US jobless figures. At 0754 AEST on Friday, the June share price index futures contract was up 12 points at 5,127. In economic news on Friday, the Reserve Bank of Australia ... |
| | | | ... from Fortescue Metals Group, Woodside Petroleum and Iluka are due for release. Bank of Queensland and Australian Pharmaceutical Industries publish their interim results, while Wesfarmers will release third quarter retail sales figures. On Wednesday ... |
| | | | The Australian market is set for a flat start despite an unexpectedly strong increase in US consumer spending in February. Wall Street rose slightly, its ninth straight session of gains. At 0800 AEDT on Thursday, the March share price index futures ... |
| | | | ... biscuits (1.7 per cent). Also down were the prices of audio, visual and computing equipment (-4.3 per cent) and pharmaceutical products (-3.5 per cent). There was also a fall in health costs recorded in the quarter. The main contributor was pharmaceutical ... |
| | | | ... $66.47. All the major banks were relatively flat. Making news, a cystic fibrosis treatment developed by Australian pharmaceutical company Pharmaxis has received a negative review from advisers to regulators in the United States, sending shares down 41 ... |
| | | | ... first-half results; Centro Retail Australia has scheduled an extraordinary meeting to vote on new name and Australian Pharmaceutical is due to hold its annual general meeting. In Australia, the market on Monday, closed slightly higher following a firm ... |
| | | | ... patients and may therefore experience an uptick." Birkhold says that lying somewhere between these camps are the pharmaceutical companies, which while likely to experience increased demand as a result of wider funding of healthcare needs, may also feel ... |
|